Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 Steal-of-a-Deal Stocks to Snap Up Right Now
01:48pm, Monday, 26'th Feb 2024
In a volatile market, many investors follow the strategy of chasing their winners higher. Money has flooded stocks such as Nvidia (NASDAQ: NVDA ).
Pfizer: Finally, A Dividend Stock Worth Buying
06:56am, Saturday, 24'th Feb 2024
Dividend stocks have been overvalued due to the influx of retirees seeking income, but Pfizer is an exception. Pfizer is trading at a good valuation and offers a decent yield with potential for growth
Pfizer Stock Has 29% Upside, Says a New Bull
11:59am, Friday, 23'rd Feb 2024
Guggenheim analysts initiated coverage of drug firm Pfizer at Buy with a $36 price target. Shares have lagged behind the market in recent years.
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
07:05am, Friday, 23'rd Feb 2024
Investors in the vulnerable global economy constantly seek the Holy Grail: stocks immune to economic downturns. As the stock markets sway with economic and geopolitical uncertainty winds, finding thos
This pharma stock surged 13% in a day
04:14am, Friday, 23'rd Feb 2024
Moderna (NASDAQ: MRNA) stock significantly surged on February 22 after the company surpassed Wall Street's quarterly expectations.
Pfizer's expectations have been rightsized, has potential for $5 EPS: Cantor Fitzgerald's Chen
03:36pm, Thursday, 22'nd Feb 2024
Louise Chen, Cantor Fitzgerald, and Michael Yee, Jefferies, joins 'Power Lunch' to discuss Chen's bull case for Pfizer, Yee's bull case for Moderna, and more.
Better Bull Market Buy: Novavax vs. Pfizer
06:10am, Thursday, 22'nd Feb 2024
Novavax is making progress along the path to recovery -- and its combined COVID/flu vaccine candidate could drive growth. Pfizer offers better growth prospects than you might think, as well as a juicy
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
10:05am, Wednesday, 21'st Feb 2024
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024
01:00pm, Tuesday, 20'th Feb 2024
U.S. indices are hitting new all-time highs seemingly every week. Traders are enthusiastic, but some analysts are warning of a potential market bubble.
Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod
08:11am, Tuesday, 20'th Feb 2024
The approval for Pfizer's (PFE) Velsipity (etrasimod) is based on data from two pivotal phase III studies, ELEVATE UC 52 and ELEVATE 12.
2 Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying, and 1 They Can't Sell Fast Enough
05:06am, Tuesday, 20'th Feb 2024
Quarterly-filed Form 13Fs allow investors to see what Wall Street's most-successful money managers have been buying and selling. Billionaire investors weren't shy about pressing the buy button during
Pfizer inflammatory bowel disease drug wins European Commission approval
08:05am, Monday, 19'th Feb 2024
Pfizer on Monday said the European Commission has approved the company's drug to treat patients with an inflammatory bowel disease called ulcerative colitis.
7 Blue-Chip Stocks to Pick Up While They're Down
04:06pm, Sunday, 18'th Feb 2024
If you are an investor like me, you don't want to miss out on any opportunity to load up on blue-chip stocks to buy when they are down. While blue-chip stocks can help build a solid retirement portfol
These are the top 10 stocks with ties to US government
12:35pm, Sunday, 18'th Feb 2024
A new research has shed light on the number of publicly traded companies with extensive connections to the United States government. Conducted by the stock market tracker Quiver Quant, the research ra
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
08:30am, Saturday, 17'th Feb 2024
Pfizer and Bristol Myers Squibb have delivered poor financial results of late. Some investors might worry about the future of their dividend programs.
